Prescient Therapeutics Ltd Webinar Presentation Transcript

Aug 15, 2022 / NTS GMT
Presentation
Aug 15, 2022 / NTS GMT

=====================
Corporate Participants
=====================
* Steven Yatomi-Clarke
Prescient Therapeutics Ltd - CEO & MD

=====================
Steven Yatomi-Clarke - Prescient Therapeutics Ltd - CEO & MD

Thanks, everyone, and welcome to hearing about Prescient, and thanks for your time today. An incredibly exciting time to be talking about cancer, and I have to pinch myself who would have thought that in 2022 we'd be talking about the beginning of the end of cancer.

Like, five short years ago, that wasn't possible, but it's happening right before our eyes. It's real-world data. And Prescient, we're an Australian-US company, but we find ourselves actually at the front of this incredible wave.

We're not scrambling out the back of it. We're positioned right in front. You're going to see why and what that means for patients and for shareholders.

Next slide. Thank you. Skipping ahead.

So, we're capped at about $100 million, between $100 million and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot